TITLE

Fatalities and failures prompt recall of cardiac defibrillators

PUB. DATE
September 2005
SOURCE
Consumer Reports;Sep2005, Vol. 70 Issue 9, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that two deaths and dozens of product failures have led to a worldwide recall of tens of thousands of cardiac defibrillators designed by the Guidant Corp., which have been implanted in patients susceptible to dangerous abnormal heart rhythms. Review of how the devices are designed to deliver a potentially lifesaving electrical shock when hearth rhythms go awry; Description of the two defibrillator models involved in the recall.
ACCESSION #
17921476

 

Related Articles

  • Boston Sci sees up-tick in Guidant ICD-related suits.  // Medical Technology & Devices Week;3/12/2007, Vol. 5 Issue 11, p3 

    The article focuses on reports from Boston Scientific about the increase in the number of lawsuits against Guidant's heart rhythm devices. The company now faces more than 1,100 individual and 75 class action lawsuits over recalls and safety warnings issued in 2005 and 2006 involving Guidant's...

  • Stuck with the check? Becker, Cinda // Modern Healthcare;6/27/2005, Vol. 35 Issue 26, p20 

    Reports on the recall of implantable cardiac defibrillators (ICD) by Guidant Corp. in the U.S. in June 2005. Cost of the device; Background on ICD; Problems encountered by patients at Indiana Heart Hospital in Indianapolis with the device.

  • YOU'RE O.K., BUT IS YOUR DEFIBRILLATOR WORKING? Horowitz, Janice M. // Time;6/23/2003, Vol. 161 Issue 25, p82 

    Discusses how heart patients that use defibrillators can check their health data by using a device made by Medtronic. How defibrillators can be used to shock a heart back into a regular rhythm.

  • Extended charge banking model of dual path shocks for implantable cardioverter defibrillators. Dosdall, Derek J.; Sweeney, James D. // BioMedical Engineering OnLine;2008, Vol. 7, Special section p1 

    Background: Single path defibrillation shock methods have been improved through the use of the Charge Banking Model of defibrillation, which predicts the response of the heart to shocks as a simple resistor-capacitor (RC) circuit. While dual path defibrillation configurations have significantly...

  • Boston Scientific: Guidant to rebound from product recall setbacks.  // PharmaWatch: Monthly Review;May2006, Vol. 5 Issue 5, p16 

    The article reports on the business performance of medical device maker Guidant Corp. The company is forecast to regain market share in the cardiac rhythm management (CRM) market, boosted by the rebound of the implantable cardioverter defibrillator market and its pending acquisition by Boston...

  • Heart implant recall shakes patients. Webster, Richard A. // New Orleans CityBusiness (1994 to 2008);7/11/2005, Vol. 25 Issue 53, p1 

    Reports on the increasing telephone calls from terrified patients following the recall of cardiac defibrillators by cardiovascular product manufacturer Guidant Corp. in the U.S. Discovery of flaw that could prevent the devices from delivering a life-saving shock to the heart; Payment of patient...

  • Boston Scientific ICD recalls.  // Materials Management in Health Care;Aug2006, Vol. 15 Issue 8, p8 

    The article reports that Massachusetts-based Boston Scientific Corp. is continuing the recall of certain models of cardiac resynchronization pacemakers and implantable cardioverter defibrillators produced by Guidant, which was acquired by Boston. The United States Food and Drug Administration...

  • In response to "Magnets and implantable cardioverter defibrillators: What's the problem?". Kumar, Rajnish // Annals of Cardiac Anaesthesia;Jul-Sep2014, Vol. 17 Issue 3, p252 

    A letter to the editor is presented in response to the article "Magnets and Implantable Cardioverter Defibrillators: What's the Problem?" by Y. F. Rodriguez-Blanco and colleagues published in the journal in 2013.

  • Voluntary recall targets defective DEFIBRILLATION leads.  // Health Facilities Management;Nov2007, Vol. 20 Issue 11, p48 

    The article reports on the voluntary removal of the Sprint Fidelis defibrillation leader of Medtronic Inc. from the market due to the potential of the electric wires to fracture. According to a statement by the U.S. Food & Drug Administration, fractures have occurred in less than 1 percent of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics